Delivery Order SPE2DB20D3101-SPE2DB25FQUQ0

Award Date 11/12/24
Potential Completion Date 11/13/24
Potential Value $6.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,080.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRIUMEQ 600-50-300 MG TABLET medication, with an ultimate completion date of June 14, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This...
This contract award, valued at $47,279.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a firm fixed-price delivery order for the supply of TRIUMEQ 600-50-300 MG TABLET UU 30S, a pharmaceutical product, with a period of performance through December 11, 2024. The award appears to be part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $6,733.24, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product, with a completion date of January 8, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $29,273.45, is a delivery order for the supply of TRIUMEQ 600-50-300 MG TABLET UU 30S, a pharmaceutical product. The contract has a period of performance through September 20, 2023 and is a Firm Fixed Price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $44,378.98 firm fixed price delivery order is for the provision of TRIUMEQ 600-50-300 MG TABLET, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical. This single-award...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $13,039.74, and has an ultimate completion date of January 21, 2025. The contract is for the supply of TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $6,080.28, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product, to support military treatment programs and facilities. The award is a firm fixed-price delivery order without any set-aside designation. It is associated with a larger indefinite delivery contract (IDC)...
This federal contract award, valued at $13,538.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for TRIUMEQ 600-50-300 MG TABLET UU 30S, a pharmaceutical product, and has an ultimate completion date of July 18, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $6,519.84 for the supply of TRIUMEQ 600-50-300 MG TABLET to support military healthcare programs. The contract has an ultimate completion date of March 11, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,080.28 firm-fixed-price delivery order contract is for the supply of TRIUMEQ 600-50-300 MG TABLET medical products. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FQUQ0
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,080.28, is for the delivery of TRIUMEQ 600-50-300 MG TABLET medication. The contract is a Firm Fixed Price Delivery Order that runs through November 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 1:45 PM